{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:13:43Z","timestamp":1778930023822,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/16\/63\/32408"],"award-info":[{"award-number":["FS\/16\/63\/32408"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jointm.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:32:12Z","timestamp":1766493132000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A potential role for trace amines in the treatment of septic shock"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-2050","authenticated-orcid":false,"given":"Kenneth J.","family":"Broadley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6906-9397","authenticated-orcid":false,"given":"Alexander C.","family":"Voisey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-6169","authenticated-orcid":false,"given":"William R.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison D.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jointm.2025.09.003_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jointm.2025.09.003_bib0002","series-title":"Septic shock. statpearls (Internet)","author":"Mahapatra","year":"2022"},{"issue":"8","key":"10.1016\/j.jointm.2025.09.003_bib0003","article-title":"Sepsis\u2014Pathophysiology and therapeutic concepts","volume":"14","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0306-3623(96)00410-7","article-title":"Nitric oxide and septic shock","volume":"29","author":"Thiemermann","year":"1997","journal-title":"Gen Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.jointm.2025.09.003_bib0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0005-2728(99)00031-6","article-title":"Nitric oxide in septic shock","volume":"1411","author":"Titheradge","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.jointm.2025.09.003_bib0006","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.ki.5002340","article-title":"Nitric oxide in shock","volume":"72","author":"Cauwels","year":"2007","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jointm.2025.09.003_bib0007","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/ajplegacy.1976.230.2.298","article-title":"Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction","volume":"230","author":"Shepherd","year":"1976","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bjp.0704079","article-title":"Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesentery organ culture model","volume":"133","author":"O\u2019Brien","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jointm.2022.05.001","article-title":"Alternatives to norepinephrine in septic shock: which agents and when?","volume":"2","author":"Jozwiak","year":"2022","journal-title":"J Intensive Med"},{"issue":"1\u20132","key":"10.1016\/j.jointm.2025.09.003_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1113\/jphysiol.1910.sp001392","article-title":"Chemical structure and sympathomimetic action of amines","volume":"41","author":"Barger","year":"1910","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1113\/jphysiol.1958.sp006104","article-title":"The action of sympathomimetic amines in animals treated with reserpine","volume":"144","author":"Burn","year":"1958","journal-title":"J Physiol"},{"issue":"9","key":"10.1016\/j.jointm.2025.09.003_bib0013","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.46.9.827","article-title":"Pressor sensitivity to tyramine in patients with headache: relationship to platelet monoamine oxidase and to dietary provocation","volume":"46","author":"Peatfield","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6\u20137","key":"10.1016\/j.jointm.2025.09.003_bib0014","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s002280100317","article-title":"Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects","volume":"57","author":"Berlin","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jointm.2025.09.003_bib0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2125.1990.tb05447.x","article-title":"Amphetamine-like effects in humans of the khat alkaloid cathinone","volume":"30","author":"Brenneisen","year":"1990","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jointm.2025.09.003_bib0016","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.jhh.1001869","article-title":"The impact of oral phenylpropanolamine on blood pressure: a met-analysis and review of the literature","volume":"19","author":"Salerno","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jointm.2025.09.003_bib0017","series-title":"Speed, ecstasy, ritalin: the science of amphetamines","author":"Iversen","year":"2006"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0018","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0269881108089809","article-title":"Safety of therapeutic methylphenidate in adults: a systematic review of the evidence","volume":"23","author":"Godfrey","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0019","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1476-5381.1967.tb02170.x","article-title":"The lack of crossed tachyphylaxis between tyramine and some other indirectly acting sympathomimetic amines","volume":"30","author":"Day","year":"1967","journal-title":"Br J Pharmacol Chemother"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.105.090035","article-title":"Pressor responses to ephedrine are mediated by a direct mechanism in the rat","volume":"316","author":"Liles","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.jointm.2025.09.003_bib0022","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejphar.2007.10.029","article-title":"Cardiovascular effects of tyramine: adrenergic and cholinergic interactions","volume":"579","author":"Khwanchuea","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0023","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.1994.tb13092.x","article-title":"Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs","volume":"112","author":"Woodman","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.jointm.2025.09.003_bib0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1440-1681.1992.tb00499.x","article-title":"Inhibition of nitric oxide synthase specifically enhances adrenergic vasoconstriction in rabbits","volume":"19","author":"Du","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jps.2600760206","article-title":"Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat","volume":"76","author":"FA","year":"1987","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0704094","article-title":"Vascular actions of MDMA involve a1 and a2-adrenoceptors in the anaesthetized rat","volume":"133","author":"McDaid","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0027","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.301.1.152","article-title":"Cardiovascular responses elicited by the \u201cbinge\u201d administration of methamphetamine","volume":"301","author":"Varner","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jointm.2025.09.003_bib0028","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.2042-7158.1982.tb04722.x","article-title":"Cardiovascular effects of (-)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine","volume":"34","author":"Kohli","year":"1982","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0029","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pharmthera.2009.11.005","article-title":"The vascular effects of trace amines and amphetamines","volume":"125","author":"Broadley","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1\u20133","key":"10.1016\/j.jointm.2025.09.003_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejphar.2013.04.034","article-title":"Functional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetamines","volume":"715","author":"Broadley","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0031","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-010-0554-1","article-title":"Identification of trace amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by \u03b2-phenylethylamine","volume":"382","author":"Fehler","year":"2010","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jointm.2025.09.003_bib0032","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejphar.2017.10.038","article-title":"Non-adrenergic vasoconstriction and vasodilatation of guinea-pig aorta by \u03b2-phenylethylamine and amphetamine \u2013 Role of nitric oxide determined with l-NAME and NO scavengers","volume":"818","author":"Broadley","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jointm.2025.09.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2019.106580","article-title":"Modulation of vascular responses of guinea-pig aorta by non-endothelial nitric oxide: a minor role for the endothelium","volume":"121","author":"Broadley","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0034","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/bjp.2008.286","article-title":"Dietary trace amine-dependent vasoconstriction in porcine coronary artery","volume":"155","author":"Herbert","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jointm.2025.09.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107191","article-title":"Trace amine-induced vasoconstriction of human mammary artery and saphenous vein","volume":"151","author":"Broadley","year":"2023","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46627-5","article-title":"Differential mechanisms of action of the trace amines octopamine, synephrine and tyramine on the porcine coronary and mesenteric artery","volume":"9","author":"Koh","year":"2019","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"10.1016\/j.jointm.2025.09.003_bib0037","first-page":"319","article-title":"Coronary and aortic vasoconstriction by cathinone, the active constituent of khat","volume":"23","author":"Al-Motarreb","year":"2004","journal-title":"Auton Autacoid Pharmacol"},{"issue":"16","key":"10.1016\/j.jointm.2025.09.003_bib0038","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jointm.2025.09.003_bib0039","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1208\/aapsj080116","article-title":"Receptors of mammalian trace amines","volume":"8","author":"Lewin","year":"2006","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.jointm.2025.09.003_bib0040","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamine, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jointm.2025.09.003_bib0041","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3389\/fphar.2017.00987","article-title":"The case for TAAR1 as a modulator of central nervous system function","volume":"8","author":"Rutigliano","year":"2018","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.jointm.2025.09.003_bib0042","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1096\/fj.06-7474com","article-title":"Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function","volume":"21","author":"Chiellini","year":"2007","journal-title":"FASEB J"},{"issue":"47","key":"10.1016\/j.jointm.2025.09.003_bib0043","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.jointm.2025.09.003_bib0044","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jointm.2025.09.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176895","article-title":"Is there a role for biogenic amine receptors in mediating \u03b2-phenylethylamine and RO5256390-induced vascular contraction?","volume":"981","author":"Voisey","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0046","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00210-024-03218-0","article-title":"Reappraisal of the mechanism of cardiovascular responses to sympathomimetic amines in anaesthetised rats: dual \u03b11-adrenoceptor and trace amine receptor mechanisms","volume":"398","author":"Broadley","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0048","first-page":"245","article-title":"Cardiovascular responses to physical exercise and tyramine infusion in hypertensive and normotensive subjects","volume":"3","author":"Colombo","year":"1989","journal-title":"J Human Hypertens"},{"issue":"9","key":"10.1016\/j.jointm.2025.09.003_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01720361","article-title":"Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects","volume":"60","author":"Bianchetti","year":"1982","journal-title":"Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0051","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005344-200301000-00016","article-title":"Pressor responses to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function","volume":"41","author":"Meck","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.jointm.2025.09.003_bib0052","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13181-022-00885-4","article-title":"The role of angiotensin II in poisoning-induced shock \u2013 a review","volume":"18","author":"Chen","year":"2022","journal-title":"J Med Toxicol"},{"issue":"5","key":"10.1016\/j.jointm.2025.09.003_bib0053","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/BPO.0b013e3182857d88","article-title":"Intraoperative anaphylaxis secondary to intraosseous gelatin administration","volume":"33","author":"Luhmann","year":"2013","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0054","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/bja\/aeh088","article-title":"Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for caesarean section","volume":"92","author":"Ngan Kee","year":"2004","journal-title":"Br J Anaesth"},{"issue":"11","key":"10.1016\/j.jointm.2025.09.003_bib0055","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S0007114508123431","article-title":"Effects of dietary amines on the gut and its vasculature","volume":"101","author":"Broadley","year":"2009","journal-title":"Br J Nutr"},{"issue":"7","key":"10.1016\/j.jointm.2025.09.003_bib0056","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1476-5381.2011.01706.x","article-title":"Vasoconstrictor and vasodilator responses to tryptamine of rat isolated perfused mesentery: comparison with tyramine and \u03b2-phenylethylamine","volume":"165","author":"Anwar","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"4 Pt 2","key":"10.1016\/j.jointm.2025.09.003_bib0057","first-page":"H1038","article-title":"Loss of vascular responsiveness induced by endotoxin involves l-arginine pathways","volume":"259","author":"Julou-Schaeffer","year":"1990","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0058","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10787-019-00622-4","article-title":"Betulinic acid attenuates lipopolysaccharide-induced vascular hyporeactivity in rat aorta by modulating Nrf2 antioxidative function","volume":"28","author":"Bai","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.jointm.2025.09.003_bib0059","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0024-3205(01)01137-7","article-title":"Nitric oxide dependent and independent effects of incubation or endotoxin on vascular reactivity in rat aorta","volume":"69","author":"Wylam","year":"2001","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jointm.2025.09.003_bib0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vph.2006.10.004","article-title":"Inhibition of src family tyrosine kinase prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteries","volume":"46","author":"Kox","year":"2007","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0061","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vph.2014.04.005","article-title":"Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors","volume":"62","author":"Zhang","year":"2014","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2025.09.003_bib0062","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1476-5381.1993.tb13436.x","article-title":"Dependence of endotoxin-induced vascular hyporeactivity on extracellular l-arginine","volume":"108","author":"Schott","year":"1993","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X25000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X25000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:04:29Z","timestamp":1778929469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X25000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2667100X25000878"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2025.09.003","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potential role for trace amines in the treatment of septic shock","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}